The AI trade took off in 2024, and Wall Street expects it to continue into next year. Here's what investors should expect ...

NervGen's groundbreaking NVG-291 treatment for spinal cord injury is currently in trials with FDA Fast Track Designation.

Neumora Therapeutics to release phase 3 data on Navacaprant for MDD treatment in 2024. Check out NMRA's catalysts that might ...

Work on the Lowell High School rebuild and renovation project will really ramp up during the school district’s holiday break, ...

Camilla Chong, MD, Chief Medical Officer of InflaRx, commented: "We are pleased to have started our Phase 2a trial for INF904 ...

According to the company, its Phase 1/2 CLARA trial of AURN001 for corneal edema demonstrated significant dose-dependent ...

Edgewise Therapeutics, Inc., (Nasdaq: EWTX), a leading muscle disease biopharmaceutical company, today announced positive topline results from the Pha ...

Kanpur: In Etawah district, a minor filed allegations against three individuals ... searching for the hospital where he underwent gender change surgery. After collecting all the facts and ...

Nvidia led the first phase of the artificial intelligence boom, but cloud computing and software companies could be the next big winners. Morgan Stanley analysts recently upgraded Cloudflare stock ...

To get selected as the Assistant Manager and Manager in SIDBI, candidates have to face three-stage selection process i.e. Phase I, Phase II & Interview. SIDBI has also announced the tentative dates ...

Nothing has been confirmed yet, but if Black Panther 3 is made, Marvel Phase 6 would be a surprise. But, then again, there are release slots to fill, and Black Panther is a pivotal character and ...